Translational medicine and Targeted therapies unit, Hôpital Necker Enfants Malades
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Canaud, Guillaume
SESAM, NCT05577754: Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)

Recruiting
2
20
Europe
Alpelisib (BYL719), Matching placebo, Optional lumbar puncture + blood sample
Centre Hospitalier Universitaire Dijon, Novartis Pharmaceuticals
Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
03/27
03/27
Bahi-Buisson, Nadia
No trials found

Download Options